Is Alimera Sciences Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ALIM) stock is to Buy ALIM stock.
Out of 1 analyst, 0 (0%) are recommending ALIM as a Strong Buy, 1 (100%) are recommending ALIM as a Buy, 0 (0%) are recommending ALIM as a Hold, 0 (0%) are recommending ALIM as a Sell, and 0 (0%) are recommending ALIM as a Strong Sell.
What is ALIM's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: ALIM) forecast ROE is N/A, which is considered weak.
What is ALIM's Price Target?
According to 1 Wall Street analyst that have issued a 1 year ALIM price target, the average ALIM price target is $5.00, with the highest ALIM stock price forecast at $5.00 and the lowest ALIM stock price forecast at $5.00.
The Wall Street analyst predicted that Alimera Sciences's share price could reach $5.00 by May 25, 2024. The average Alimera Sciences stock price prediction forecasts a potential upside of 91.57% from the current ALIM share price of $2.61.
What is ALIM's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: ALIM) forecast ROA is -8.75%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of -9.4%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.